EUVIMEDEUVIMED entdecken
Open Access

The SOX4-Semaphorin3C axis promotes esophageal adenocarcinoma progression

Tala Fnu, Peiguo Shi, Wanwei Zhang, Yinshan Fang, Yosuke Mitani, Yong Zhang, Joel Gabre, Wael Ei-Rifai, Alexandar Zaika, Qixuan Chen, Jian Zhu, Timothy C Wang und 2 weitere

Cancer Letters · 2025-11 · 633 · 218005

DOI: 10.1016/j.canlet.2025.218005 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Letters, 2025-11. Verfasst von Tala Fnu und 13 weiteren Autor:innen. Beteiligte Einrichtung: Columbia Center for Human Development, Department of Medicine, Vagelos College of Physicians and Surgeons, Columbia University Irving Medical Center,…. Hauptthemen laut MEDLINE: SOXC Transcription Factors, Esophageal Neoplasms, Adenocarcinoma, Semaphorins. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NIDDK NIH HHS, BLRD VA.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Esophageal adenocarcinoma (EAC) is an aggressive malignancy with an approximately 700 % increase in incidence in Western countries over the past four decades. However, the molecular mechanism driving cancer progression remains elusive. In this study we have identified that SOX4, a transcription factor, is enriched in EACs. SOX4 knockdown or deletion leads to a significant reduction in tumor growth and metastasis. Through integrating RNA-Seq and ChIP-Seq we identified Semaphorin 3C (SEMA3C) as an important downstream target of SOX4. Consistently, knockdown of SEMA3C reduced the growth of EAC cells in vitro and xenografts, accompanied by attenuated epithelial-mesenchymal transition. Our findings identifiy a molecular mechanism through which SOX4 regulates SEMA3C to promote tumor progression, offering potential translational therapeutic target (s) for EAC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SOXC Transcription FactorsEsophageal NeoplasmsAdenocarcinomaSemaphorinsHumansAnimalsDisease ProgressionGene Expression Regulation, NeoplasticEpithelial-Mesenchymal TransitionCell Line, TumorMiceCell ProliferationSignal Transduction

Substanzen

SOXC Transcription FactorsSOX4 protein, humanSemaphorins

Autor:innen und Institutionen

  • Columbia Center for Human Development, Department of Medicine, Vagelos College of Physicians and Surgeons, Columbia University Irving Medical Center, New York, NY, 10032, USA; Herbert Irving Comprehensive Cancer Center,…
  • Cardiometabolic Genomics Program, Division of Cardiology, Department of Medicine, Columbia University Irving Medical Center, New York, NY, 10032, USA; Department of System Biology, Columbia University Irving Medical Cen…
  • Department of Microbiology and Immunology, Vagelos College of Physicians and Surgeons, Columbia University Irving Medical Center, New York, NY, 10032, USA.
  • Herbert Irving Comprehensive Cancer Center, Vagelos College of Physicians and Surgeons, Columbia University Irving Medical Center, New York, NY, 10032, USA; Division of Digestive and Liver Disease, Department of Medicin…
  • Hunter Biotechnology, Inc, Hangzhou, China.
  • Department of Surgery, Miller School of Medicine, University of Miami, Miami, FL, USA; Sylvester Comprehensive Cancer Center, Miller School of Medicine, University of Miami, Miami, FL, USA; Department of Veterans Affair…

Förderung

  • NCI NIH HHS
  • NIDDK NIH HHS
  • BLRD VA
  • National Natural Science Foundation of China
  • National Institutes of Health National Cancer Institute
  • Columbia University
  • AGA Research Foundation
  • National Institute of Diabetes and Digestive and Kidney Diseases

Zitieren

APA

Fnu, T., Shi, P., Zhang, W., Fang, Y., Mitani, Y., Zhang, Y., Gabre, J., Ei-Rifai, W., Zaika, A., Chen, Q., Zhu, J., Wang, T. C., Jiang, M., & Que, J. (2025). The SOX4-Semaphorin3C axis promotes esophageal adenocarcinoma progression. Cancer Letters, 633, 218005. https://doi.org/10.1016/j.canlet.2025.218005

Vancouver

Fnu T, Shi P, Zhang W, Fang Y, Mitani Y, Zhang Y, et al. The SOX4-Semaphorin3C axis promotes esophageal adenocarcinoma progression. Cancer Letters. 2025;633:218005. doi:10.1016/j.canlet.2025.218005

BibTeX
@article{Fnu2025,
  author = {Fnu, Tala and Shi, Peiguo and Zhang, Wanwei and Fang, Yinshan and Mitani, Yosuke and Zhang, Yong and Gabre, Joel and Ei-Rifai, Wael and Zaika, Alexandar and Chen, Qixuan and Zhu, Jian and Wang, Timothy C and Jiang, Ming and Que, Jianwen},
  title = {The SOX4-Semaphorin3C axis promotes esophageal adenocarcinoma progression},
  journal = {Cancer Letters},
  year = {2025},
  volume = {633},
  pages = {218005},
  doi = {10.1016/j.canlet.2025.218005}
}
Kostenlos starten →